Literature DB >> 30553188

Clinicopathological characteristics of metaplastic breast cancer - analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types.

M P Budzik1, J Patera2, M Sobol1, A I Czerw3, A Deptała4, A M Badowska-Kozakiewicz1.   

Abstract

INTRODUCTION: Metaplastic breast cancer (MpBC) is a rare but aggressive type of breast cancer accounting for 0.25-1% of all diagnosed invasive breast cancers. Morphologically, it is characterized by differentiation of the neoplastic epithelium into squamous cells and/or mesenchymal-looking tissue.
MATERIAL AND METHODS: We analyzed 13 MpBCs selected from the group of 1122 invasive breast cancers. Histopathological examination and analysis of estrogen (ER), progesterone (PR) and HER2 receptors expression in MpBC patients and their comparison to other types of invasive breast cancer has been performed.
RESULTS: 13 MpBC cases represented 1.16% of the 1122 invasive breast cancers. The MpBC group presented with a significantly larger tumor size (≥T2, 69% versus 49%, p < 0.001) and with higher grade of histological malignancy (G1-G3) (p < 0.001). MpBC group had significantly more cases with no hormone receptors (ER, PR) and HER2 overexpression/gene amplification compared with the other invasive breast cancer types group (ER-, 69% versus 23%, p < 0.001; PR-, 69% versus 28%, p < 0.001; HER2 0/1+, 93% versus 82%, p = 0.019). Most MpBCs (62%) were triple-negative. We found a correlation between hormone receptors expression and lymph node metastasis (p < 0.001). The analysis of the HER2 expression allowed us to find correlation between its expression and tumor histological grade (G1-G3) (p < 0.001), tumor size (T1a-T4) (p < 0.001) and lymph node metastasis (pN0-pN4) (p < 0.001) in MpBCs. DISCUSSION: MpBCs are usually larger at primary diagnosis and most of MpBCs present with other poor prognostic indicators and show lack of steroid hormone receptors expression as well as HER2. Hormone receptor status and HER2 expression seems to correlate with histological grade of malignancy (G1-G3), tumor size (T1a-T4) and regional lymph node involvement (pN0-pN4) and these features are directly related to MpBC malignancy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Estrogen receptor; Metaplastic breast carcinoma; Progesterone receptor; Triple-negative breast cancer

Mesh:

Substances:

Year:  2018        PMID: 30553188     DOI: 10.1016/j.breast.2018.12.004

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  9 in total

1.  Prognostic Significance of p16 Protein Expression in Breast Cancer.

Authors:  Magdi M Salih; Amjed A Higgo; Emad M Eed
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].

Authors:  W Cai; Y Zhuang; J Chen; H Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

3.  Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.

Authors:  Saroona Haroon; Shamail Zia; Umme Aiman Shirazi; Omer Ahmed; Ishaq Azeem Asghar; Muhammad Asad Diwan; Anoshia Afzal; Muhammad Irfan; Syed Jawwad Ali; Atif A Hashmi
Journal:  Cureus       Date:  2021-04-07

4.  Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special type.

Authors:  Michał Piotr Budzik; Marta Magdalena Fudalej; Anna Maria Badowska-Kozakiewicz
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

5.  Medullary breast cancer is a predominantly triple-negative breast cancer - histopathological analysis and comparison with invasive ductal breast cancer.

Authors:  Michał P Budzik; Maciej T Sobieraj; Maria Sobol; Janusz Patera; Aleksandra Czerw; Andrzej Deptała; Anna M Badowska-Kozakiewicz
Journal:  Arch Med Sci       Date:  2019-07-17       Impact factor: 3.318

6.  Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.

Authors:  Ying-Zi Li; Bo Chen; Xiao-Yi Lin; Guo-Chun Zhang; Jian-Guo Lai; Cheukfai Li; Jia-Li Lin; Li-Ping Guo; Wei-Kai Xiao; Hsiaopei Mok; Chong-Yang Ren; Ling-Zhu Wen; Fang-Rong Cao; Xin Lin; Xiao-Fang Qi; Yang Liu; Ning Liao
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

7.  Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC.

Authors:  Rilan Bai; Lin Jia; Yangyang Gao; Xu Sun; Naifei Chen; Zheng Lv; Jiuwei Cui
Journal:  Thorac Cancer       Date:  2022-08-16       Impact factor: 3.223

8.  Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma.

Authors:  Qing-Cong Kong; Wen-Jie Tang; Si-Yi Chen; Wen-Ke Hu; Yue Hu; Yun-Shi Liang; Qiong-Qiong Zhang; Zi-Xuan Cheng; Di Huang; Jing Yang; Yuan Guo
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

9.  Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like.

Authors:  Shaoqiang Cheng; Bingshu Xia; Hongbin Li; Yuying Li; Xinxin Lv; Yue Zhang; Yuanxi Huang
Journal:  Cancer Cell Int       Date:  2020-07-17       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.